CVRdatabase
Menu

Abbott Laboratories A/S

Public limited companyCVR 31528615København SActive

Abbott Laboratories A/S is a public limited company, based in København S, active in wholesale of medical and hospital supplies, founded in 1971. Net profit rose 663% from 2024 to 2025, ending at DKK 63.1m. With 48 employees, the company is about 10 times larger than the industry median. Equity fell to DKK 74.4m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 412.8m+17.8% vs. 2024
Net profitDKK 63.1m+662.9% vs. 2024
EquityDKK 74.4m−47.3% vs. 2024
Employees48latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 5% (2024 → 2025), to DKK 66.8m.
  • Revenue rose 18% (2024 → 2025), to DKK 412.8m.
  • Net profit rose 663% (2024 → 2025), to DKK 63.1m.
  • Equity fell 47% (2024 → 2025), to DKK 74.4m.

Registrations, last 24 months

  • 04/11/2024: Moved to Arne Jacobsens Allé 13, 2, 2300 København S

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120mDKK 140m202020212022202320242025
EquityNet profit
Financial figures for Abbott Laboratories A/S
202020212022202320242025Change
Revenue195,944259,193268,116327,404350,377412,832+17.8%
Gross profit39,74644,15951,18362,59863,56466,799+5.1%
Operating profit (EBIT)6,1537,6948,04313,33013,26414,747+11.2%
Profit before tax6,2897,6787,98311,70711,03666,001+498%
Net profit4,8255,9746,0989,1688,27663,143+662.9%
Total assets164,580183,202207,593218,289262,577197,809−24.7%
Equity111,715117,689123,788132,956141,23274,375−47.3%
Liabilities52,20563,64782,03983,216121,345123,434+1.7%
Cash and cash equivalents3,5034,18134,82212,87822,90816,486−28%
Average number of employees363944504948−2%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m202020212022202320242025
Gross profitMedian, the industry (187 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Equity fell sharply

    Equity fell 47% from 2024 to 2025 (DKK 141.2m to DKK 74.4m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Abbott Laboratories A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202523/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202326/06/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202228/06/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202108/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202009/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

187 companies in the database

Comparison with the other companies in wholesale of medical and hospital supplies based on the latest financial year.

Gross profitDKK 66.8mNo. 16 of 187
Better than 92% of the companies in the industry
EquityDKK 74.4mNo. 21 of 187
Better than 89% of the companies in the industry
Number of employees48No. 20 of 187
Better than 90% of the companies in the industry

Industry median: gross profit DKK 5.8m, net profit DKK 1.2m, equity DKK 5.4m, 5 employees.

DKK 100kDKK 795kDKK 6.3mDKK 50.3mDKK 200.3mHere
Distribution of gross profit for 179 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 264of 9,892
Better than 97%
No. 481of 9,922
Better than 95%
Same industry and 20–49 employees28 companies in the comparison
No. 3of 28
Better than 93%
No. 5of 28
Better than 85%
Companies that are at least 30 years old10,276 companies in the comparison
No. 1,179of 10,152
Better than 88%
No. 1,548of 10,275
Better than 85%
All companies of type A/S18,025 companies in the comparison
No. 2,257of 17,786
Better than 87%
No. 2,768of 18,024
Better than 85%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of medical and hospital supplies
Gross profit
  1. Abbott Laboratories A/SDKK 66.8m
  2. Orifarm Generics A/SDKK 399.8m
  3. 3shape Trios A/SDKK 203.5m
Net profit
  1. Abbott Laboratories A/SDKK 63.1m
  2. Orifarm Generics A/SDKK 77.2m
  3. 3shape Trios A/SDKK 58.4m
Equity
  1. Abbott Laboratories A/SDKK 74.4m
  2. Orifarm Generics A/SDKK 496.3m
  3. 3shape Trios A/SDKK 121.7m
Employees
  1. Abbott Laboratories A/S48
  2. Orifarm Generics A/S255
  3. 3shape Trios A/S56

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Abbott Medical Overseas Cyprus Limited100%
Abbott Laboratories A/S
Subsidiaries and ownership shares

Subsidiaries are shown only if they are in the database.

Management

4 active registrations

Executive management

Executive management at Abbott Laboratories A/S
NameRoleAppointed
Karl Andreas AlmrothCEO01/03/2023

Board of directors

Board of directors at Abbott Laboratories A/S
NameRoleAppointed
Fredrik Björn Anders BjörnulfsonBoard member01/01/2013
Bradley Jay SlaterChair of the board29/08/2022
Karl Andreas AlmrothBoard member01/03/2023
Former management (47)
Former management at Abbott Laboratories A/S
NameRoleAppointedResigned
Leif RamtungBoard member04/02/197128/11/1990
Leif RamtungCEO04/02/197128/11/1990
Jan-Erik CollinBoard member04/02/197103/02/2004
Odd Inge Vaage-NilsenDirector04/02/197104/09/1996
Mark Francis GormanDirector04/02/197127/08/1998
Christer ØhlundBoard member04/02/197123/02/1994
Christer ØhlundDirector04/02/197123/02/1994
Thomas Richard HodgsonChair of the board04/02/197120/06/1991
Jonh Duncan McIntyreBoard member04/02/197105/03/1993
Alain Joseph Marie GilbertChair of the board04/02/197129/09/1987
Mark Collier MillerBoard member04/02/197123/01/1990
Ian BlackBoard member04/02/197120/06/1991
Ian BlackDirector04/02/197120/06/1991
Arthur Joseph HigginsBoard member04/02/197105/03/1993
Arthur Joseph HigginsDirector04/02/197105/03/1993
Robert Leory Parkinson, jrBoard member04/02/197105/03/1993
Gary Patrick CoughlanChair of the board04/02/197124/04/2002
Ørn Reidar StugeChair of the board04/02/197103/07/1995
Siegfried BruneChair of the board04/02/197127/08/1998
Siegfried BruneDirector04/02/197122/04/1998
John AfsethChair of the board04/02/197122/04/1998
Mark Francis GormanBoard member22/04/199827/08/1998
Henricus Adrianus Maria Lambertus van de LaarBoard member27/08/199812/07/2002
Henricus Adrianus Maria Lambertus van de LaarDirector27/08/199812/07/2002
Jean Paul KressBoard member12/07/200231/01/2006
Jean Paul KressDirector12/07/200231/01/2006
Thomas Craig FreymanChair of the board12/07/200226/02/2016
Kate TørnøBoard member03/02/200418/12/2008
Laurent Van LerbergheBoard member31/01/200624/09/2007
Laurent Van LerbergheDirector31/01/200624/09/2007
Alexander WürfelBoard member24/09/200703/12/2009
Alexander WürfelDirector24/09/200703/12/2009
Tom SchjødtBoard member18/12/200801/01/2013
Christina Dyreborg JeppesenBoard member03/12/200901/01/2013
Christina Dyreborg JeppesenCEO03/12/200901/01/2013
Erik Hjalmar BjörkmanBoard member01/01/201330/11/2013
Erik Hjalmar BjörkmanCEO01/01/201330/11/2013
Palle Michael ChristensenBoard member30/11/201327/02/2015
Palle Michael ChristensenCEO30/11/201327/02/2015
Jorun Klokk HolstBoard member27/02/201501/03/2016
Jorun Klokk HolstCEO27/02/201501/03/2016
Brian B. YoorChair of the board26/02/201622/01/2019
Peter Frønsdal ToftBoard member01/03/201611/11/2016
Peter Frønsdal ToftCEO01/03/201611/11/2016
Ole Martin Alfstad ChristiansenBoard member11/11/201601/03/2023
Ole Martin Alfstad ChristiansenCEO11/11/201601/03/2023
Benjamin Edward OosterbaanChair of the board22/01/201929/08/2022

Signing rule: Selskabet tegnes af den administrerende direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Arne Jacobsens Allé 13
2300 København S

København Municipality · Postcode 2300

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
ABBOTT LABORATORIES A/SArne Jacobsens Allé 13, 2, 2300 København S481001676792

Purpose

Selskabets formål er at drive handel med farmaceutiske produkter, kemiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til Selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.

The purpose is quoted from the register in Danish.

Changes year by year

120 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20251 changeaccounts 1
  • Annual report for 2024 published
20243 changesaddress 2 · accounts 1
  • Moved to Arne Jacobsens Allé 13, 2, 2300 København S
  • Annual report for 2023 published
  • Moved to Produktionsvej 14, 2600 Glostrup
20237 changesownership 2 · accounts 1 · management 4
  • ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED registered as owner (100%)
  • St. Jude Medical International Holding is no longer registered as owner
  • Annual report for 2022 published
  • Karl Andreas Almroth appointed ceo
  • Karl Andreas Almroth appointed board member
  • Ole Martin Alfstad Christiansen stepped down as ceo
  • Ole Martin Alfstad Christiansen stepped down as board member
20223 changesmanagement 2 · accounts 1
  • Bradley Jay Slater appointed chair of the board
  • Benjamin Edward Oosterbaan stepped down as chair of the board
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20193 changesaddress 1 · management 2
  • Moved to Emdrupvej 28C, 2100 København Ø
  • Benjamin Edward Oosterbaan appointed chair of the board
  • Brian B. Yoor stepped down as chair of the board
20181 changeaddress 1
  • Moved to Emdrupvej 28C, 2100 København Ø
20172 changesownership 2
  • St. Jude Medical International Holding registered as owner (100%)
  • Abbott Investments Luxembourg S.à r.l. is no longer registered as owner
201610 changesmanagement 10
  • Ole Martin Alfstad Christiansen appointed ceo
  • Ole Martin Alfstad Christiansen appointed board member
  • Peter Frønsdal Toft stepped down as board member
  • Peter Frønsdal Toft stepped down as ceo
  • Peter Frønsdal Toft appointed board member
  • Peter Frønsdal Toft appointed ceo
  • Jorun Klokk Holst stepped down as board member
  • Jorun Klokk Holst stepped down as ceo
  • Brian B. Yoor appointed chair of the board
  • Thomas Craig Freyman stepped down as chair of the board
20154 changesmanagement 4
  • Jorun Klokk Holst appointed board member
  • Jorun Klokk Holst appointed ceo
  • Palle Michael Christensen stepped down as ceo
  • Palle Michael Christensen stepped down as board member
201310 changesmanagement 10
  • Palle Michael Christensen appointed ceo
  • Palle Michael Christensen appointed board member
  • Erik Hjalmar Björkman stepped down as board member
  • Erik Hjalmar Björkman stepped down as ceo
  • Erik Hjalmar Björkman appointed board member
  • Fredrik Björn Anders Björnulfson appointed board member
  • Erik Hjalmar Björkman appointed ceo
  • Christina Dyreborg Jeppesen stepped down as ceo
  • Christina Dyreborg Jeppesen stepped down as board member
  • Tom Schjødt stepped down as board member
20122 changescapital 1 · ownership 1
  • Share capital changed from 4,025,000 DKK to 4,026,000 DKK
  • Abbott Investments Luxembourg S.à r.l. registered as owner (100%)
20111 changemerger 1
  • Merger registered in CVR
20094 changesmanagement 4
  • Christina Dyreborg Jeppesen appointed ceo
  • Christina Dyreborg Jeppesen appointed board member
  • Alexander Würfel stepped down as director
  • Alexander Würfel stepped down as board member
20082 changesmanagement 2
  • Tom Schjødt appointed board member
  • Kate Tørnø stepped down as board member
20075 changesaddress 1 · management 4
  • Moved to Emdrupvej 28, c, 2100 København Ø
  • Alexander Würfel appointed director
  • Alexander Würfel appointed board member
  • Laurent Van Lerberghe stepped down as director
  • Laurent Van Lerberghe stepped down as board member
20064 changesmanagement 4
  • Laurent Van Lerberghe appointed director
  • Laurent Van Lerberghe appointed board member
  • Jean Paul Kress stepped down as director
  • Jean Paul Kress stepped down as board member
20042 changesmanagement 2
  • Kate Tørnø appointed board member
  • Jan-Erik Collin stepped down as board member
20026 changesmanagement 6
  • Jean Paul Kress appointed director
  • Jean Paul Kress appointed board member
  • Thomas Craig Freyman appointed chair of the board
  • Henricus Adrianus Maria Lambertus van de Laar stepped down as director
  • Henricus Adrianus Maria Lambertus van de Laar stepped down as board member
  • Gary Patrick Coughlan stepped down as chair of the board
19991 changemerger 1
  • Merger registered in CVR
19989 changesmanagement 8 · capital 1
  • Henricus Adrianus Maria Lambertus van de Laar appointed director
  • Henricus Adrianus Maria Lambertus van de Laar appointed board member
  • Mark Francis Gorman stepped down as board member
  • Siegfried Brune stepped down as chair of the board
  • Mark Francis Gorman stepped down as director
  • Mark Francis Gorman appointed board member
  • John Afseth stepped down as chair of the board
  • Siegfried Brune stepped down as director
  • Share capital changed from 3,550,000 DKK to 4,025,000 DKK
19961 changemanagement 1
  • Odd Inge Vaage-Nilsen stepped down as director
19951 changemanagement 1
  • Ørn Reidar Stuge stepped down as chair of the board
19942 changesmanagement 2
  • Christer Øhlund stepped down as director
  • Christer Øhlund stepped down as board member
19934 changesmanagement 4
  • Robert Leory Parkinson, jr stepped down as board member
  • Arthur Joseph Higgins stepped down as director
  • Arthur Joseph Higgins stepped down as board member
  • Jonh Duncan McIntyre stepped down as board member
19921 changecapital 1
  • Share capital changed from 300,000 DKK to 3,550,000 DKK
19913 changesmanagement 3
  • Ian Black stepped down as director
  • Ian Black stepped down as board member
  • Thomas Richard Hodgson stepped down as chair of the board
19903 changesmanagement 3
  • Leif Ramtung stepped down as board member
  • Leif Ramtung stepped down as ceo
  • Mark Collier Miller stepped down as board member
19871 changemanagement 1
  • Alain Joseph Marie Gilbert stepped down as chair of the board
197122 changesfounded 1 · management 21
  • Registered as ABBOTT LABORATORIES A/S
  • Siegfried Brune appointed chair of the board
  • Ørn Reidar Stuge appointed chair of the board
  • Gary Patrick Coughlan appointed chair of the board
  • Robert Leory Parkinson, jr appointed board member
  • Arthur Joseph Higgins appointed director
  • Arthur Joseph Higgins appointed board member
  • Ian Black appointed director
  • Ian Black appointed board member
  • Mark Collier Miller appointed board member
  • Alain Joseph Marie Gilbert appointed chair of the board
  • Jonh Duncan McIntyre appointed board member
  • Thomas Richard Hodgson appointed chair of the board
  • Christer Øhlund appointed director
  • Christer Øhlund appointed board member
  • Mark Francis Gorman appointed director
  • Odd Inge Vaage-Nilsen appointed director
  • Jan-Erik Collin appointed board member
  • Leif Ramtung appointed board member
  • Leif Ramtung appointed ceo
  • John Afseth appointed chair of the board
  • Siegfried Brune appointed director

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction